NeoVax Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

NeoVax General Information

Description

Developer of vaccines. The company is engaged in developing vaccines for several infectious diseases including H5N1 influenza virus.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
  • 6812 Idylwild
  • Boulder, CO 80301
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

NeoVax Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore NeoVax‘s full profile, request access.

Request a free trial

NeoVax Executive Team (1)

Name Title Board Seat Contact Info
Jose Sandoval President
To view NeoVax’s complete executive team members history, request access »